Nucleic Acid Template and the Risk of a PCR-Induced HIV-1 Drug Resistance Mutation by Varghese, Vici et al.
Nucleic Acid Template and the Risk of a PCR-Induced








Svetlana Jean M. Mappala
1, Baback Gharizadeh






1Department of Medicine, Stanford University School of Medicine, Stanford, California, United States of America, 2Stanford Genome Technology Center, Stanford
University School of Medicine, Stanford, California, United States of America, 3Department of Pediatrics, Stanford University School of Medicine, Stanford, California,
United States of America, 4Clinical Trials Unit, Kaiser-Permanente Medical Care Program-Northern California, San Francisco, California, United States of America
Abstract
Background: The HIV-1 nucleoside RT inhibitor (NRTI)-resistance mutation, K65R confers intermediate to high-level
resistance to the NRTIs abacavir, didanosine, emtricitabine, lamivudine, and tenofovir; and low-level resistance to stavudine.
Several lines of evidence suggest that K65R is more common in HIV-1 subtype C than subtype B viruses.
Methods and Findings: We performed ultra-deep pyrosequencing (UDPS) and clonal dideoxynucleotide sequencing of
plasma virus samples to assess the prevalence of minority K65R variants in subtype B and C viruses from untreated
individuals. Although UDPS of plasma samples from 18 subtype C and 27 subtype B viruses showed that a higher
proportion of subtype C viruses contain K65R (1.04% vs. 0.25%; p,0.001), limiting dilution clonal sequencing failed to
corroborate its presence in two of the samples in which K65R was present in .1.5% of UDPS reads. We therefore performed
UDPS on clones and site-directed mutants containing subtype B- and C-specific patterns of silent mutations in the
conserved KKK motif encompassing RT codons 64 to 66 and found that subtype-specific nucleotide differences were
responsible for increased PCR-induced K65R mutation in subtype C viruses.
Conclusions: This study shows that the RT KKK nucleotide template in subtype C viruses can lead to the spurious detection
of K65R by highly sensitive PCR-dependent sequencing techniques. However, the study is also consistent with the subtype
C nucleotide template being inherently responsible for increased polymerization-induced K65R mutations in vivo.
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Introduction
The HIV-1 reverse transcriptase (RT) mutation K65R is one of
the most important HIV-1 drug resistance mutations. It confers
intermediate to high-level resistance to the nucleoside reverse
transcriptase (RT) inhibitors (NRTIs) abacavir, didanosine,
emtricitabine, lamivudine, and tenofovir, as well as low-level
resistance to stavudine [1,2,3]. Three lines of evidence suggest that
K65R may be more likely to emerge in subtype C than subtype B
viruses from individuals with virologic failure: (i) K65R has been
reported to emerge more rapidly during in vitro passage of subtype
C than in subtype B viruses in the presence of tenofovir [4]. (ii)
Observational studies have suggested that K65R emerges in a
higher proportion of individuals infected with subtype C who
develop virologic failure following combination antiretroviral
(ARV) therapy than in those infected with subtype B viruses
[5,6]. (iii) Two laboratories have described preferential RT
pausing at the nucleotide position responsible for the AAG-to-
AGG K65R mutation during positive-strand DNA synthesis of a
subtype C, but not a subtype B, nucleotide template [7,8,9]
We performed ultra-deep pyrosequencing (UDPS; 454 Life
Sciences/Roche, Branford, CT) to ascertain whether K65R can
be detected in minority HIV-1 variants from ARV-naı ¨ve
individuals infected with subtype C viruses. We also performed
UDPS on site-directed mutants and clonal dideoxynucleotide
(Sanger) sequencing to assess the influence of PCR-induced
mutation in RT genes in the highly conserved KKK RT motif
spanning codons 64 to 66 in subtype B and C viruses.
Methods
Database analysis of patterns of silent mutations at RT
codons 64 to 66 in subtype B and C viruses
We used the HIV Drug Resistance Database [10] to identify
patterns of silent mutations at RT codons 63 to 66 in subtype B
and C viruses. Because codon 63 — ATA, or isoleucine — is
nearly invariant, we examined the nine nucleotides of the wildtype
KKK motif in viruses obtained from untreated individuals and of
the mutant KRK motif (i.e. with the mutation K65R) in viruses
from NRTI-treated individuals. Because direct PCR sequences are
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[11] and because plasma HIV-1 genomes are more likely than
proviral DNA genomes to encode viable viruses [12] we analyzed
only direct PCR sequences obtained from plasma HIV-1 isolates.
Clinical HIV-1 samples
We sequenced HIV-1 RT genes from 18 ARV-naı ¨ve subtype C-
infected individuals whose plasma samples contained HIV-1 RNA
levels .4.5 log copies/ml and from which we were able to extract
more than 100 distinct virus templates. Sixteen of the samples
were obtained between 1999 and 2008 from individuals in the
U.S.; two were obtained in 1996 from individuals in Zimbabwe. A
collection of 27 virus-load-matched subtype B plasma samples
from ARV-naı ¨ve individuals were used as controls. We have
obtained ethical approval from the Stanford University Institu-
tional Review Board. Because the research involved samples that
had already been collected and because the samples were not
linked to protected health information, the Institutional Approval
included a waiver of informed consent.
Plasmid clones with subtype B and C nucleotide patterns
at the conserved KKK motif
Four types of plasmid clones were created: (i): Four PCR-
amplified RT fragments from clinical samples encompassing
codons 1 to 127 with the two most common subtype B (AAG-
AAA-AAA, AAG-AAA-AAG) and C (AAA-AAG-AAG, AAA-
AAG-AAA) KKK patterns were cloned into the pCR2.1 vector
(Invitrogen, Carlsbad, CA). (ii) Four PCR-amplified subtype B RT
fragments from clinical samples encompassing codons 1 to 127
with the two most common subtype C nucleotide patterns were
cloned into the pCR2.1 vector. The large number of subtype B
plasma samples available to us allowed us to identify these rare
subtype B viruses with subtype C KKK nucleotide patterns. (iii)
Site-directed mutants (QuickChange XL Site Directed Mutagen-
esis Kit, Stratagene, La Jolla, CA) containing the two most
common subtype C nucleotide patterns in the subtype B pNL43
clone. (iv) Site-directed mutants containing the two most common
subtype B nucleotide patterns in one of the subtype C pCR2.1
clones described above.
Ultradeep pyrosequencing
Plasma samples were ultracentrifuged and submitted for RNA
extraction and reverse transcription using the Roche Amplicor
RNA extraction kit and SuperScriptIII RT enzyme (Invitrogen,
Carlsbad, CA). The resulting cDNA was submitted for limiting
dilution PCR to ensure the presence of .100 distinct cDNA
templates. Nested PCRs were then used to amplify RT codons 1 to
127 using both the Taq-Pwo enzyme mix (Expand High
Fidelity
PLUS PCR System, Roche Diagnostics) and the high
fidelity polymerase PfuUltra II Fusion (Stratagene, La Jolla, CA).
Each of the primers used for PCR amplification, including one
previously described set of primers and one set optimized for
subtype C viruses, is shown in supplementary Table S1.
Sequencing was bidirectional with approximately 57% of reads
generated by the forward (59) primers and 43% of reads generated
by the reverse (39) primers. The KKK motif was approximately
180 nucleotides downstream from the start of the sequence
generated by the 59 primers and 180 nucleotides downstream from
the start of the sequence generated by the 39 primers.
Plasmid prep DNA was diluted to approximately 100 distinct
DNA templates and PCR amplified using Taq-Pwo enzyme mix
(Expand High Fidelity
PLUS PCR System, Roche Diagnostics) and
the high-fidelity enzyme PfuUltra II Fusion (Stratagene, La Jolla,
CA). PfuUltra II Fusion was not used for clinical samples because
its amplification efficiency on variable virus templates is often poor
[13]. However, it was possible to use PfuUltra II Fusion to amplify
the plasmid clones because the primers hybridized perfectly to the
plasmid template.
PCR products were purified by AMPure kit (Agencourt
Biosciences, Beverly, MA), quantified using Quant-iT Picogreen
(Invitrogen, Carlsbad, CA), and pooled at equimolar concentra-
tions. Clonal amplification on beads (emulsion PCR) was
performed using reagents (emPCR kits II and III; 454 Life
Sciences, Branford, CT) that enable bidirectional sequencing.
DNA-containing beads were recovered and UDPS was performed
on a Genome Sequencer FLX (454 Life Sciences, Branford, CT);
each sample pool was loaded in one region of a 70 mm675 mm
PicoTiter plate (454 Life Sciences, Branford, CT) fitted with a
four-lane gasket. For 16 of the 18 subtype C samples, UDPS was
performed in duplicate on different PicoTiter plates. For these 16
samples, the text reports the mean of the duplicate test results. The
coefficient of variation between the two runs was calculated to
assess the reproducibility of UDPS on these samples.
Dideoxynucleoside (Sanger) sequencing
Direct PCR Sanger sequencing encompassing protease and RT
codons 1 to 240 was performed on all plasma samples prior to the
start of the study using a previously described method [14]. Sanger
sequencing of molecular and limiting dilution clones derived from
two clinical plasma samples was performed to verify UDPS results.
Molecular cloning involved ligating PCR amplicons encompassing
codons 1 to 127 into a TA cloning vector (pCR2.1), transforming
One ShotH TOP 10F9 Chemically Competent E.coli (Invitrogen,
Carlsbad, CA), and sequencing plasmid preps generated from
individual colonies.
Limiting dilution (LD) clonal sequencing involved subjecting
serially diluted cDNA to PCR amplification and sequencing those
products resulting from dilutions at which no more than one in
three PCR reactions were positive. Sequences lacking electropho-
retic mixtures were considered clones and those with electropho-
retic mixtures were considered oligoclonal. The thermostable
DNA polymerase enzyme mix Taq-Pwo (Expand High Fidelity
PLUS
PCR System) was used for amplification of both molecular and
limiting dilution clones. Whereas molecular clones frequently
contain detectable PCR errors, limiting dilution clones rarely do
because even an error occurring during the first cycle of PCR
amplification will rarely be apparent in the final sequence.
Results
Database analysis of patterns of silent mutations at RT
codons 64 to 66 in subtype B and C viruses
Table 1 compares the variation at the silent third nucleotide
position at codons 64 to 66 in HIV-1 subtype B and C viruses.
Viruses with the wildtype KKK motif were obtained from NRTI-
naı ¨ve individuals and viruses with the K65R mutation from
NRTI-treated individuals. In the untreated wildtype samples, the
two most common variants in subtype B viruses differed from the
two most common subtype C variants. The two most common
subtype B variants accounted for 97% of the eight possible KKK-
encoding nucleotide patterns; six other variants accounted for the
remaining 3% of patterns. The two most common subtype C
variants accounted for 98% of the eight possible KKK-encoding
nucleotide patterns; six variants accounted for the remaining 2%
of patterns.
The nucleotide patterns encoding KRK in the subtype B and C
isolates from NRTI-treated individuals occurred in proportions
PCR-Induced K65R Mutation
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the second position of codon 65. Forty individuals had a pre-
therapy KKK sample and a post-therapy KRK sample. All but
two of the post-therapy samples were identical to the pre-therapy
sample except for the presence of an A to G substitution at the
second position of codon 65.
UDPS of subtype B and C plasma virus samples from
ARV-naı ¨ve individuals
Figure 1 shows that UDPS detected K65R in a higher
proportion of sequence reads of subtype C plasma samples than
in subtype B plasma samples (1.04% vs. 0.25%; p,0.001
Wilcoxon Rank Sum Test). K65R was detected in at least 1.0%
of reads in 8/18 (44%) subtype C samples and in 1/27 (3.7%)
subtype B samples (p=0.01; Fisher’s Exact Test).
Table 2 shows the dominant wildtype KKK nucleotide patterns
in the UDPS reads of the 18 subtype C and 27 subtype B viruses
and the KRK nucleotide patterns for those samples in which
K65R was present in at least 1.0% of UDPS reads. The two most
common subtype B wildtype KKK nucleotide patterns matched
the two most commonly reported subtype B nucleotide patterns.
The most common dominant subtype C wildtype KKK nucleotide
pattern matched the most commonly reported subtype C
nucleotide pattern.
Among the subtype B samples, K65R was detected in more
than 1.0% of reads in a sample with a complex mixture of KKK
nucleotide variants including AAA-AAG-AAA (the second-most
common subtype C pattern) in 38% of reads, AAG-AAA-AAA
(the most common subtype B pattern) in 7% of reads, and an
uncommon pattern AAG-AAG-AAA in 50% of reads. Despite the
fact that the K65R reads in this subtype B sample (1.1% of all
reads) were encoded by AAA-AGA-AAA, there were no reads
with the closest wildtype variant, AAA-AAA-AAA.
AmongthesubtypeCsamples,K65Rwasdetectedinatleast1.0%
of reads in eight samples, including 7 of 11 with the most common
subtype C pattern and the one sample with the second-mostcommon
subtype C pattern. Of the four subtype C samples with the most
commonly reported subtype B KKK nucleotide variant (AAG-AAA-
AAA), none had K65R in 1.0% or more of reads.
The coefficient of variation for the duplicate UDPS runs on the
subtype C sequences was 0.23. For eight of the 16 repeated subtype
C samples, the proportion of reads with K65R was .1.0% in each
of the duplicate runs and for seven of the 16 repeated subtype C
samples, the proportion of reads with K65R was ,1.0% on both
runs. The median proportion of reads with K65R was similar in the
forward (0.93%) and reverse (1.2%) UDPS reads.
Clonal analysis of two subtype C viruses for which more
than 2.0% of UPDS reads contained K65R
To determine whether the high frequency of K65R reads in
subtype C viruses reflected a natural occurrence of this mutation at
low levels in subtype-C-infected individuals or a technical artifact
of either PCR or UDPS, we performed clonal dideoxynucleotide
sequencing on the two subtype C viruses with the highest
proportions of K65R reads. Table 3 shows that, although 133 of
5186 UDPS reads of sample SCR268 had K65R, none of 265
limiting dilution clones of the same sample had the mutation
(p=0.001; Fisher’s Exact Test). Similarly, although 57 of 3613
UDPS reads of sample 9635 had K65R, none of the 254 limiting
dilution clones we sequenced of this sample had the mutation
(p=0.02, Fisher’s Exact Test). In contrast, there was no
statistically significant difference in the number of UDPS vs.
molecular clones for sample SCR268 (6 of 278 vs. 133 of 5186;
p=0.8) or 9635 (3 of 278 vs. 57 of 3613; p=0.8). Although
limiting dilution sequencing did not detect K65R, it did detect
each of the other 33 nucleotide and three amino acid mutations
Table 1. Comparison of Nucleotide Patterns in Subtype B and Subtype C HIV-1 Reverse Transcriptase Codons 64, 65 and 66 in the
HIV Drug Resistance Database.
NRTI-Naı ¨ve Individuals with K65K NRTI-Treated Individuals with K65R
64K 65K 66K % (n=7423) 64K 65R 66K % (n=365)
AAG AAA AAA 82.73 AAG AGA AAA 78.63
AAG AAA AAG 14.25 AAG AGA AAG 17.26
AAG AAG AAA 1.90 AAG AGG AAA 1.37
AAA AAG AAA 0.70 AAA AGG AAA 1.10
AAA AAG AAG 0.28 AAA AGG AAG 0.27
AAG AAG AAG 0.08 - - - -
AAA AAA AAA 0.03 AAA AGA AAA 1.10
AAA AAA AAG 0.03 AAA AGA AAG 0.27
64K 65K 66K % (n=2048) 64K 65R 66K % (n=46)
AAA AAG AAG 88.48 AAA AGG AAG 91.30
AAA AAG AAA 9.47 AAA AGG AAA 8.70
AAG AAG AAG 0.88
AAG AAA AAG 0.34
AAG AAA AAA 0.29
AAA AAA AAG 0.24
AAG AAG AAA 0.24
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samples. Taken together, the limiting dilution and molecular
cloning sequencing results strongly suggest that PCR error was
responsible for the subsequent frequent false positive detection of
K65R by UDPS of subtype C samples.
UDPS KKK sequences of site-directed mutants and
plasmid clones
Table 4 shows that a median of 1.2% of 454 UDPS reads
(range: 0.7%–1.3%) of the eight clones with the two most common
subtype C KKK patterns had K65R. In contrast, the four clones
Figure 1. Comparison of Ultra-Deep Pyrosequencing (UDPS) Results of Subtype B and Subtype C Clinical HIV-1 Samples. Proportion
of UDPS reads containing K65R in 18 subtype C and 27 subtype B viruses from anti retroviral-naı ¨ve individuals. For 16 of the 18 subtype C samples,
UDPS was performed twice. The figure shows the mean proportion of K65R for the duplicate runs. The median proportion of K65R reads per sample
were 0.25% for subtype B and 1.04% for subtype C.
doi:10.1371/journal.pone.0010992.g001
Table 2. Dominant Intra-Individual Pattern of Nucleotides Coding for K64, K65 and K66 in 27 Subtype B and 18 Subtype C Isolates
from Untreated Individuals: Association with presence of K65R as Determined by Ultra-Deep Pyrosequencing (UDPS)*.
Subtype KKK Motif (wildtype K65K) No. Isolates K65R ($1.0%) KRK Sequence (K65R)
B AAG AAG AAA{ 1 1 (1.1%) AAA AGA AAA
AAA AAG AAG 0 0 Not applicable
AAG AAA AAA 22 0 Not applicable
AAG AAA AAG 4 0 Not applicable
AAG AAG AAG 0 0 Not applicable
C AAA AAG AAA 1 1 (2.1%) AAA AGG AAA
AAA AAG AAG 12 7 (1.0% to 2.3%) AAA AGG AAG
AAG AAA AAA 4 0 Not applicable
AAG AAA AAG 0 0 Not applicable
AAG AAG AAG 1 0 Not applicable
*The column ‘‘KKK Motif’’ indicates the Sanger sequence of the codons 65 to 67 in the plasma virus samples. The column ‘‘No. Isolates’’ indicates the number of
individuals with the Sanger sequence shown in the ‘‘KKK Motif column’’. The column ‘‘K65R ($1.0%)’’ indicates the number of samples for which $1.0% of the reads had
K65R. The range in proportions is shown in parentheses. The proportion of reads with K65R was determined by dividing the number of reads with K65R by the total
number of sequencing reads encompassing codon 65.
{This sample had a complex mixture of KKK nucleotide variants including AAA-AAG-AAA (the second-most common subtype C pattern) in 38% of reads, AAG-AAA-AAA
(the most common subtype B pattern) in 7% of reads, and the uncommon pattern AAG-AAG-AAA in 50% of reads.
doi:10.1371/journal.pone.0010992.t002
PCR-Induced K65R Mutation
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a median of 0.15% of reads (range 0.1%–0.3%; P=0.007;
Wilcoxan Rank Sum Test). The proportion of UDPS reads
containing K65R appeared to be entirely dependant on the KKK
pattern in the sample. The subtype from which the surrounding
viral sequence was derived did not significantly influence the
number of reads with K65R. For plasmid clones with a subtype C
nucleotide pattern, UDPS detected K65R in a mean 1.1% of reads
(range 0.7–1.3). In contrast, for plasmid clones with a subtype B
nucleotide pattern, UDPS detected K65R in a mean of 0.2% reads
(range 0.1–0.3).
For clones with three subtype C KKK patterns, cDNA was
amplified with PfuUltra II Fusion, as well as Taq/Pwo polymerase
(Expand High Fidelity
PLUS PCR System). The proportion of
K65R clones was 16-fold to 80-fold lower in the samples amplified
using PfuUltra II Fusion than in the samples amplified with Taq/
Pwo (Table 4 footnote).
Discussion
Inter-subtype nucleotide differences have been shown to influence
the likelihood of certain HIV-1 drug resistance mutations. For
example, subtype C viruses are significantly more likely than subtype
B viruses to develop the non-nucleoside RT-inhibitor-resistance
mutationV106Mbecausethismutationrequiresasinglesubstitution
for subtype C viruses (GTGRATG) but two substitutions for
subtype B viruses (GTARATG) [15,16]. However, such a
mechanism cannot explain a preference for K65R in subtype C
viruses because a change from K to R requires a single substitution
regardless of the underlying nucleotide template (AAARAGA or
AAGRAGG).
Although UDPS detected K65R in a median of 1.0% of
sequence reads of subtype C plasma samples, Sanger sequencing
of limiting dilution and molecular clones from the two samples
with the highest proportions of K65R strongly suggested that the
UDPS data resulted from PCR error. Molecular clones are subject
to PCR errors because a PCR error occurring during an early
round of amplification will result in large numbers of clones
containing a sequencing error. Limiting dilution sequencing
circumvents this problem because even if an error occurs in the
first cycle to PCR, it will be present in no more than 25% of the
bases at that position in the amplified DNA and would not result
in an erroneous base call when the amplified DNA is sequenced
[11].
Table 3. Comparison of Ultra-Deep Pyrosequencing (UDPS) with Limiting Dilution Clonal Sequence on the Two Samples with the
Highest Proportion of K65R.
Sample UDPS{ Limiting Dilution Clones p Value*
UDPS reads K65R reads % K65R reads Total clones K65R clones % K65R clones
SCR268 5186 133 2.6% 265 0 0 p=0.001
9635 3613 57 1.6% 254 0 0 p=0.02
*Fisher’s Exact Test.
{Total reads from two separate UDPS runs. The proportion of reads with K65R was 2.9% for one UDPS run and 1.9% for the second UDPS run for SCR268. Overall, 2.6%
of total reads contained K65R. The proportion of reads with K65R was 2.7% for one UDPS run and 1.2% for the second UDPS run for 9635. Overall, 1.6% of total reads
contained K65R.
doi:10.1371/journal.pone.0010992.t003
Table 4. Ultradeep-Pyrosequencing of PCR-Induced Mutations at Codon 65 in Plasmid Clones with Different KKK Nucleotide












pCR2.1 SDM C C1 AAA-AAG-AAG 7308 0.7
NL43 SDM B C1 AAA-AAG-AAG 4726 0.8*
pCR2.1 Amplicon B C1 AAA AAG AAG 14742 1.3
pCR2.1 Amplicon B C1 AAA AAG AAG 15255 1.1
NL43 SDM B C2 AAA-AAG-AAA 6175 1.2*
pCR2.1 Amplicon C C2 AAA-AAG-AAA 2881 1.1*
pCR2.1 Amplicon B C2 AAA AAG AAA 12424 1.2
pCR2.1 Amplicon B C2 AAA AAG AAA 14216 1.3
NL43 Amplicon B B1 AAG AAA AAA 6407 0.1*
pCR2.1 SDM C B1 AAGA A A AAA 6755 0.2*
NL43 SDM B B2 AAG AAA AAG 4789 0.1
pCR2.1 SDM C B2 AAGA A AA A G 6270 0.3*
SDM, Site directed mutant; Amplicon subtype, subtype of RT codons 1–127; Underlined bases indicate bases changed by SDM; Reads at codon 65, average number of
reads or sequence coverage at codons 64 to 66.
*Samples for which PfuUltra II Fusion was used in addition to Taq-Pwo polymerase. The % of K65R reads with PfuUltra II Fusion ranged from 0.02 to 0.05 for the three
samples with the subtype C nucleotide patterns and 0 to 0.09 for the three samples with B nucleotide patterns.
doi:10.1371/journal.pone.0010992.t004
PCR-Induced K65R Mutation
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containing the two most common subtype B (AAG-AAA-AAA
and AAG-AAA-AAG) and C (AAA-AAG-AAG and AAA-AAG-
AAA) nucleotide templates demonstrates unequivocally that the
sequence of this template alone was sufficient to explain the higher
PCR error rate with subtype C nucleotide templates. These
experiments also confirm that it was PCR error, rather than
pyrosequencing that accounts for the spurious finding of K65R.
Indeed, K65R was not detected by UDPS when the high fidelity
PCR enzyme PfuUltra II Fusion was used. The fact that codon 63
has an invariant ATA sequence is consistent with the idea that the
increased likelihood of K65R is due to the stretch of six
consecutive T’s encountered during positive-strand DNA synthesis
of subtype C (but not subtype B) templates [7].
Our study has two important implications. First, it shows that
the RT KKK nucleotide template in subtype C viruses can lead to
the spurious detection of K65R by highly sensitive PCR-
dependent sequencing techniques such as UDPS or deep
molecular clonal sequencing. The risk of such ‘‘false-positive’’
results can be reduced by using PCR enzymes with higher fidelity
and by decreasing the need for PCR during upstream processing.
Second, our finding that the likelihood of identifying K65R varies
with viral subtype is consistent with the work of Coutsinos et al [7].
Thus, even though naturally occurring K65R variants do not
appear to be present in ARV-naı ¨ve individuals at levels detectable
by currently available deep sequencing technologies, we cannot
exclude the possibility that the steady state levels of such variants
are higher in subtype C compared with subtype B virus isolates.
Supporting Information
Table S1 PCR Amplification Strategy for Ultra-deep Pyrose-
quencing of Subtype C Samples.
Found at: doi:10.1371/journal.pone.0010992.s001 (0.03 MB
DOC)
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